Urorec 4 mg hard capsules

Patient Information Leaflet

Introduction

Patient Information Leaflet

Urorec 8 mg hard capsules

Urorec 4 mg hard capsules

Silodosin

Read the entire leaflet carefully before you start taking this medicine, as it contains important information for you.

• Keep this leaflet, as you may need to read it again.
• If you have any questions, ask your doctor or pharmacist.
• This medicine has been prescribed for you only, and you should not give it to other people, even if they have the same symptoms as you, because it may harm them.
• If you experience any adverse effects, consult your doctor or pharmacist, even if such effects are not listed in this leaflet. See section 4.

Leaflet Contents:

1. What Urorec is and what it is used for
2. What you need to know before taking Urorec
3. How to take Urorec
4. Possible adverse effects
5. How to store Urorec
6. Contents of the pack and further information

1. What Urorec is and what it is used for

What Urorec is

Urorec belongs to a group of medicines called selective alpha1A-adrenergic receptor blockers.

Urorec is selective for receptors located in the prostate, bladder, and urethra. By blocking these receptors, it causes relaxation of the smooth muscle in these tissues. This makes it easier for you to urinate and relieves your symptoms.

What Urorec is used for

Urorec is used in adult men to treat urinary symptoms associated with benign enlargement of the prostate (benign prostatic hyperplasia, BPH), such as:

• difficulty starting urination
• feeling of not completely emptying the bladder
• increased need to urinate, even during the night

2. What you need to know before taking Urorec

Do not take Urorec

if you are allergic to silodosin or to any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor or pharmacist before taking Urorec

• If you are scheduled for eye surgery due to clouding of the lens (cataract surgery), it is important that you immediately inform your ophthalmologist that you are currently taking or have previously taken Urorec. This is because some patients treated with this type of medicine have experienced loss of muscular tone in the iris (the colored circular part of the eye) during this type of surgery. The ophthalmologist can then take appropriate precautions regarding the medical and surgical techniques to be used. Ask your doctor whether it is necessary to delay or temporarily interrupt treatment with Urorec prior to cataract surgery.

• If you have ever fainted or felt dizzy upon standing up suddenly, inform your doctor before taking Urorec.

When taking Urorec, you may experience dizziness and, occasionally, fainting, especially when starting treatment or if you are taking other medicines that lower blood pressure. If this occurs, sit or lie down immediately until symptoms resolve and inform your doctor as soon as possible (see also section “Driving and use of machines”).

• If you have severe liver problems, you should not take Urorec, as it has not been evaluated in this condition.

• If you have kidney problems, consult your doctor.

If you have moderate kidney problems, your doctor will start treatment with Urorec cautiously and may prescribe a lower dose (see section 3 “Dosage”).

If you have severe kidney problems, you should not take Urorec.

• Since benign enlargement of the prostate and prostate cancer may cause similar symptoms, your doctor will examine you to rule out prostate cancer before starting treatment with Urorec. Urorec is not effective in treating prostate cancer.

• Treatment with Urorec may lead to abnormal ejaculation (reduced amount of semen ejaculated during sexual intercourse), which may temporarily affect male fertility. This effect resolves after stopping Urorec. Inform your doctor if you are planning to have children.

Sodium

This medicine contains less than 1 mmol of sodium (23 mg) per capsule; i.e., essentially “sodium-free”.

Children and adolescents

Do not give this medicine to children and adolescents under 18 years of age, as there are no relevant indications for this age group.

Taking Urorec with other medicines

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

In particular, inform your doctor if you are taking:

• medicines that lower blood pressure (especially alpha1-blockers such as prazosin or doxazosin), as there may be a potential risk that the effect of these medicines is increased during treatment with Urorec.
• antifungal medicines (such as ketoconazole or itraconazole), medicines used for HIV/AIDS infection (such as ritonavir), or medicines used after organ transplantation to prevent organ rejection (such as cyclosporine), as these medicines may increase blood levels of Urorec.
• medicines used to treat difficulty achieving or maintaining an erection (such as sildenafil or tadalafil), as their concomitant use with Urorec may lead to a slight decrease in blood pressure.
• medicines for epilepsy or rifampicin (a medicine used to treat tuberculosis), as the effect of Urorec may be reduced.

Pregnancy and breastfeeding

Urorec is not indicated for use in women.

Fertility

Urorec may reduce the amount of semen and temporarily affect your ability to father a child. If you intend to father a child, consult your doctor or pharmacist before using this medicine.

Driving and use of machines

Do not drive or operate machinery if you feel faint, dizzy, or drowsy, or if you experience blurred vision.

3. How to take Urorec

Follow exactly the instructions for use of this medicine provided by your doctor or pharmacist. If you are in doubt, consult your doctor or pharmacist again.

The recommended dose is one Urorec 8 mg capsule per day, taken orally.

Always take the capsule with food, preferably at the same time each day. Do not break or chew the capsule; swallow it whole, preferably with a glass of water.

Patients with kidney problems

If you have moderate kidney problems, your doctor may prescribe a different dose. For this purpose, Urorec 4 mg hard capsules are available.

If you take more Urorec than you should

If you have taken more than one capsule, inform your doctor as soon as possible. If you experience dizziness or feel weak, tell your doctor immediately.

If you forget to take Urorec

You may take the capsule later the same day if you forgot to take it earlier. If it is almost time for your next dose, do not take the missed dose. Do not take a double dose to make up for the forgotten capsule.

If you stop taking Urorec

If you stop treatment, your symptoms may return.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone experiences them.

Contact your doctor immediately if you experience any of the following allergic reactions, as they could have serious consequences: swelling of the face or throat, difficulty breathing, feeling faint, skin itching or hives.

The most common adverse effect is a reduction in the amount of semen ejaculated during sexual intercourse. This effect disappears after stopping treatment with Urorec. Inform your doctor if you are planning to have children.

Dizziness, including dizziness upon standing, and occasionally fainting, may occur.

If you feel weak or dizzy, sit or lie down immediately until symptoms subside. If you experience dizziness upon standing or fainting, inform your doctor as soon as possible.

Urorec may cause complications during cataract surgery (eye surgery due to lens clouding; see section “Warnings and precautions”).

It is important that you inform your ophthalmologist immediately if you are currently taking or have previously taken Urorec.

The possible adverse effects are listed below:

Very common adverse effects (may affect more than 1 in 10 people)

• Abnormal ejaculation (reduced or negligible amount of semen ejaculated during sexual intercourse; see section “Warnings and precautions”)

Common adverse effects (may affect up to 1 in 10 people)

• Dizziness, including dizziness upon standing (see also above in this section)
• Nasal discharge or nasal congestion
• Diarrhea

Uncommon adverse effects (may affect up to 1 in 100 people)

• Loss of sexual appetite
• Nausea
• Dry mouth
• Difficulty achieving or maintaining an erection
• Increased heart rate
• Skin allergic reaction symptoms such as rash, pruritus, urticaria, and drug-induced rash
• Abnormal liver function test results
• Low blood pressure

Rare adverse effects (may affect up to 1 in 1,000 people)

• Fast or irregular heartbeats (known as palpitations)
• Fainting/loss of consciousness

Very rare adverse effects (may affect up to 1 in 10,000 people)

• Other allergic reactions with swelling of the face or throat

Frequency not known (frequency cannot be estimated from available data)

• Floppy iris during cataract surgery (see also above in this section). Inform your doctor if you notice that your sexual activity is affected.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this leaflet. You may also report them directly through the national reporting system included in Appendix V. By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Urorec

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date stated on the carton and blister pack after "EXP". The expiry date refers to the last day of the month indicated.

Do not store above 30°C.

Keep in the original packaging to protect from light and moisture.

Do not use this medicine if you notice that the packaging is damaged or shows signs of tampering.

Medicines must not be disposed of via wastewater or household waste. Ask your pharmacist how to properly dispose of unused medicines and their packaging. This will help protect the environment.

6. Contents of the pack and other information

Composition of Urorec

Urorec 8 mg

The active substance is silodosin. Each capsule contains 8 mg of silodosin.

The other components are pregelatinized corn starch, mannitol (E421), magnesium stearate, sodium lauryl sulfate, gelatin, titanium dioxide (E171).

Urorec 4 mg

The active substance is silodosin. Each capsule contains 4 mg of silodosin.

The other components are pregelatinized corn starch, mannitol (E421), magnesium stearate, sodium lauryl sulfate, gelatin, titanium dioxide (E171), yellow iron oxide (E172).

Appearance of the product and contents of the pack

Urorec 8 mg are hard gelatin capsules, opaque and white in colour, size 0 (approximately 21.7 x 7.6 mm).

Urorec 4 mg are hard gelatin capsules, opaque and yellow in colour, size 3 (approximately 15.9 x 5.8 mm).

Urorec is available in packs containing 5, 10, 20, 30, 50, 90, 100 capsules. Only certain pack sizes may be marketed.

Marketing Authorisation Holder

Recordati Ireland Ltd.

Raheens East

Ringaskiddy Co. Cork

Ireland

Manufacturer

Recordati Industria Chimica e Farmaceutica S.p.A.

Via Matteo Civitali 1

20148 Milan

Italy

Laboratoires Bouchara-Recordati

Parc Mécatronic

03410 Saint Victor

France

Further information on this medicinal product is available upon request from the local representative of the marketing authorisation holder:

Date of the most recent review of this leaflet

Other sources of information

Detailed information on this medicinal product is available on the European Medicines Agency website: https://www.ema.europa.eu.